This modified design for the CRISPR gene editing tool could eventually improve therapies for HIV and sickle cell diseaseNovember 7, 2019
City of Hope’s cell experiments show more effective genetic ‘cuts’ that could one day become the foundation of new and more effective gene therapies.
City of Hope’s Michael Caligiuri, M.D., formally appointed to Deana and Steve Campbell Physician-in-Chief Distinguished ChairNovember 7, 2019
Michael A. Caligiuri, M.D., president of City of Hope National Medical Center, has been appointed the Deana and Steve Campbell Physician-in-Chief Distinguished Chair in Honor of Alexandra Levine, M.D.
City of Hope, San Antonio Regional Hospital host grand opening for new City of Hope cancer center in Inland EmpireOctober 24, 2019
The opening shortens the commute for residents of Upland and of most nearby cities who are seeking leading-edge oncology treatment.
Betty Ferrell, director of the Division of Nursing Research and Education at City of Hope, elected to esteemed National Academy of MedicineOctober 21, 2019
The National Academy of Medicine (NAM) today announced the election of 90 regular members and 10 international members during its annual meeting. Betty Ferrell is among the list.
Amazon has chosen City of Hope to provide state-of-the-art cancer support services to Amazon employees.
Last night, City of Hope raised more than $4 million at a black-tie gala honoring Epic Records Chairwoman and CEO Sylvia Rhone.
Harlan Levine, M.D., president of strategy and business ventures at City of Hope, joins the governing board of the bioscience ecosystem catalyst, BioLA.
The trial, which received a $4.1 million in grants from the National Institutes of Health and Gateway for Cancer Research, combines City of Hope’s unique CAR T cell therapy with immune checkpoint inhibitors
Paradigm Sports Management founder and CEO, Audie Attar, to be honored at 25th annual Fight for Life to benefit City of HopeOctober 1, 2019
Audie Attar, founder and CEO of Paradigm Sports Management, will be honored at the 25th annual Fight for Life, taking place on Sunday, Nov. 17, 2019, at The Novo at L.A. LIVE in downtown Los Angeles.
First chimeric antigen receptor (CAR) T cell therapy targeting B cell-activating factor receptor (BAFF-R) eradicates blood cancers that relapsed after CD19 CAR T therapiesSeptember 25, 2019
City of Hope’s research on the new CAR T, published in Science Translational Medicine, offers hope for patients who have relapsed after commercially available CD19 immunotherapy treatments.